financetom
Business
financetom
/
Business
/
Progress Software Insider Sold Shares Worth $1,020,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Progress Software Insider Sold Shares Worth $1,020,000, According to a Recent SEC Filing
Apr 15, 2024 2:22 PM

04:56 PM EDT, 04/15/2024 (MT Newswires) -- David Krall, Director, on April 11, 2024, sold 20,000 shares in Progress Software ( PRGS ) for $1,020,000. Following the Form 4 filing with the SEC, Krall has control over a total of 86,641 shares of the company, with 86,641 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/876167/000087616724000082/xslF345X03/wk-form4_1713214338.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pediatrix Names Mark Ordan Chief Executive
Pediatrix Names Mark Ordan Chief Executive
Jan 13, 2025
07:37 AM EST, 01/13/2025 (MT Newswires) -- Pediatrix Medical Group ( MD ) said Monday it has appointed Executive Chair Mark Ordan as chief executive officer. Ordan succeeds James Swift, the company said. Pediatrix also said it expects its 2024 adjusted earnings before interest, taxes, depreciation, and amortization to reach or exceed the high end of its $205 million-to-$215 million...
Market Chatter: Eli Lilly Sues Medical Spas for Selling Unapproved Tirzepatide Products
Market Chatter: Eli Lilly Sues Medical Spas for Selling Unapproved Tirzepatide Products
Jan 13, 2025
07:37 AM EST, 01/13/2025 (MT Newswires) -- Eli Lilly ( LLY ) filed lawsuits against two medical spas, Thrive Health and Wellness and Valhalla Vitality, accusing them of selling unapproved drugs claiming to contain tirzepatide, the active ingredient in its weight-loss medication Zepbound, Reuters reported Monday. Lilly alleges that both companies are making false claims about their products' efficacy, purity,...
LNG exporter Venture Global seeks up to $110 bln valuation in blockbuster US IPO
LNG exporter Venture Global seeks up to $110 bln valuation in blockbuster US IPO
Jan 13, 2025
* Venture Global launches 2025's first blockbuster US IPO * LNG exporter seeks as much as $2.3 bln in New York IPO * Set to be one of the biggest US energy listings ever * Venture Global has vaulted into the top ranks of LNG exporters (Adds background on company in paragraphs 15 and 16, and milestone in paragraphs 9...
Dexcom forecasts 2025 revenue mostly in-line with expectations
Dexcom forecasts 2025 revenue mostly in-line with expectations
Jan 13, 2025
Jan 13 (Reuters) - Dexcom ( DXCM ) forecast total annual revenue in line with Wall Street expectations on Monday, on bets of strong demand for its continuous glucose monitors for diabetes patients. The company expects annual revenue of $4.60 billion in 2025, compared with analysts' estimate of $4.61 billion, according to data compiled by LSEG. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved